Foghorn Therapeutics Inc.

NASDAQ: FHTX · Real-Time Price · USD
4.34
-0.09 (-2.03%)
At close: May 13, 2025, 9:46 AM

Foghorn Therapeutics Revenue

Foghorn Therapeutics reported an annual revenue of $22.6M, reflecting a -33.83% growth. For the quarter ending December 31, 2024, Foghorn Therapeutics generated $2.86M in revenue.
Revenue (ttm)
$22.6M
Revenue Growth
-33.83%
Price / Sales Ratio
11.46
Revenue / Employee
$201.8K
Employees
112
Market Cap
241.83M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.